Objective To develop a nurse-patient interaction integrated APP "NET Home" to provide detailed care and follow-up management for patients with neuroendocrine tumors (NENs) treated with long-acting octreotide.
Methods "NET Home" APP included three ports: patient side, medical side and management side. After discharge, NENs patients timely and comprehensive fed back on adverse reactions and discomfort symptoms through APP, and medical staff timely guided patients to deal with them online.
Results At 1 year after "NET Home" APP application, 45 patients registered (injected with long-acting octreotide once every 28 days). A total of 145 copies of Micro-nutrition Evaluation Scales, 147 Tumor Patients' Quality of Life Rating scales, 102 Pain Digital Evaluation Scales, 103 Adverse Reactions Questionnaire of Long-acting Octreotide Injection, 102 Self-care Ability Scales, 111 Self-rating Scales for depression and 102 Self-rating Scales for anxiety were collected. The medical staff treated 5 cases of adverse reactions by APP, and gave timely handling to 1 case of severe adverse reactions (the patient eventually stopped long-acting octreotide therapy). Compared with NENs patients who did not use APP, anxiety scores of NENs patients who used APP decreased (P < 0.05); their satisfaction scores and quality of life scores were improved, and the number of unplanned admissions decreased, but the differences showed no statistically significant (P > 0.05).
Conclusion "NET Home" APP can realize refined and personalized nursing intervention through multiple module functions, which can realize continuous home care for NENs patients, relieve their anxiety and improve their self-management ability, quality of life and treatment compliance.
DownLoad: